Lee Kyung-Jong, Shang Zeng-Fu, Lin Yu-Fen, Sun Jingxin, Morotomi-Yano Keiko, Saha Debabrata, Chen Benjamin P C
Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Radiobiology, School of Radiation Medicine and Protection, Medical College of Soochow University, School for Radiological and Interdisciplinary Sciences, Suzhou, Jiangsu, China.
Neoplasia. 2015 Apr;17(4):329-38. doi: 10.1016/j.neo.2015.02.004.
DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is the key regulator of the non-homologous end joining pathway of DNA double-strand break repair. We have previously reported that DNA-PKcs is required for maintaining chromosomal stability and mitosis progression. Our further investigations reveal that deficiency in DNA-PKcs activity caused a delay in mitotic entry due to dysregulation of cyclin-dependent kinase 1 (Cdk1), the key driving force for cell cycle progression through G2/M transition. Timely activation of Cdk1 requires polo-like kinase 1 (Plk1), which affects modulators of Cdk1. We found that DNA-PKcs physically interacts with Plk1 and could facilitate Plk1 activation both in vitro and in vivo. Further, DNA-PKcs-deficient cells are highly sensitive to Plk1 inhibitor BI2536, suggesting that the coordination between DNA-PKcs and Plk1 is not only crucial to ensure normal cell cycle progression through G2/M phases but also required for cellular resistance to mitotic stress. On the basis of the current study, it is predictable that combined inhibition of DNA-PKcs and Plk1 can be employed in cancer therapy strategy for synthetic lethality.
DNA依赖性蛋白激酶催化亚基(DNA-PKcs)是DNA双链断裂修复的非同源末端连接途径的关键调节因子。我们之前报道过,维持染色体稳定性和有丝分裂进程需要DNA-PKcs。我们进一步的研究表明,DNA-PKcs活性的缺乏会导致有丝分裂起始延迟,这是由于细胞周期蛋白依赖性激酶1(Cdk1)失调所致,Cdk1是驱动细胞周期通过G2/M期转换的关键驱动力。Cdk1的及时激活需要polo样激酶1(Plk1),而Plk1会影响Cdk1的调节因子。我们发现DNA-PKcs与Plk1存在物理相互作用,并且在体外和体内都能促进Plk1的激活。此外,DNA-PKcs缺陷型细胞对Plk1抑制剂BI2536高度敏感,这表明DNA-PKcs与Plk1之间的协同作用不仅对于确保细胞周期正常通过G2/M期至关重要,而且对于细胞抵抗有丝分裂应激也是必需的。基于当前的研究,可以预测,联合抑制DNA-PKcs和Plk1可用于癌症治疗策略中的合成致死作用。